CRISPR and Genome Editing – Products

Build your own instrument – fully automated cell imaging and picking. Use the instrument configurator to design your very own customized CellCelector, perfectly tailored to meet your unique needs.

Explore our new AAV Titer ELISA and AAV Antibody Assay Kits, designed for exceptional specificity, sensitivity, and accuracy to elevate your gene therapy research.

This whitepaper explores how AAV titration and anti-AAV antibody ELISA kits streamline AAV-based gene therapy research, enhancing patient stratification, optimizing preclinical studies and supporting regulatory compliance.

Thermo Fisher Scientific has introduced the Invitrogen Vivofectamine™ Delivery Solutions to provide high-performance lipid nanoparticles (LNP) technology for non-viral delivery of nucleic acids.

BioPharmaSpec has officially announced three new European facilities. The new facilities will focus on discovery and R&D services, offering structural and physicochemical characterization services for a wide variety of biopharmaceutical products.

SEKISUI Diagnostics’ microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion at its UK site for clinical-grade drug substance manufacturing.

ELEVECTA™ producer cell line is a true producer cell line with all four required genes ― rep, helper, cap, and gene of interest (GOI) ― stably integrated into the host cell’s genome.

Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders, is pleased to announce that a genetic medicines customer has selected to progress to the final commercial development phase for Optimer delivery vehicles.

Access this collection of resources to explore how capillary electrophoresis (CE) and mass spectrometry (MS) solutions can help you ensure the quality, safety and efficacy of your new drug candidates.

This compendium explores analytical advancements in cell and gene therapy, highlighting the latest tools and strategies for ensuring therapeutic quality.